Rheinmetall Books Fresh Ammo and Drone Orders While Shares Sit Deep in the Red

Rheinmetall booked a low three-digit million-euro 155mm shell order and a $7.28M US Marine Corps Mission Master SP deal as its stock sits 50% below its 52-week peak.

Rheinmetall has picked up two new pieces of business on opposite sides of the Atlantic, reinforcing the picture of a defense contractor whose order intake keeps humming even as its equity struggles to find a floor.

The larger of the two is an artillery munitions contract. An international customer has placed a five-figure order for 155-millimeter shells with the Düsseldorf-based group, a deal worth a low three-digit million-euro amount. Rheinmetall booked the order in the third quarter of 2026. Production is already under way, with full delivery to the buyer scheduled to wrap up by the end of 2027 — a reminder of how persistent demand for heavy ammunition remains among international partners.

Meeting that demand is a capacity question as much as a commercial one. Rheinmetall is pushing ahead with an expansion of its production lines, targeting roughly 1.5 million 155-millimeter shells a year by 2030. Securing precursor materials is the pivotal variable in hitting that goal. Industry-wide, the likeliest bottleneck is propellant powder made from nitrocellulose and nitroguanidine. To reduce its reliance on outside suppliers for that component, Rheinmetall is putting EUR 350 million into a new powder plant at Aschau am Inn in Bavaria.

A Modest U.S. Win, but a Telling One

Separately, the company's American arm has landed a smaller but strategically useful award. American Rheinmetall will supply the U.S. Marine Corps with twelve Mission Master SP autonomous ground vehicles plus five amphibious kits. The USD 7.28 million order was placed on Thursday through the Defense Logistics Agency, with ADS Inc. acting as prime contractor. The end user is the Marine Corps Warfighting Laboratory, which will put the unmanned platforms through testing.

The Mission Master SP's engineering base comes from Rheinmetall Canada, while manufacturing takes place in the United States. The vehicles carry PATH autonomy technology and are fitted with a dedicated marine kit for maritime operations.

On its own, the contract value is minor. Set against a string of comparable U.S. bookings in recent weeks, however, it underscores Rheinmetall's growing foothold in the American market for unmanned ground systems. For a group valued at a good EUR 46 billion, orders in the low single-digit millions carry no financial weight — yet they give investors a read on continuing appetite for unmanned systems built on Rheinmetall technology.

The Tape Tells a Harder Story

Neither announcement has done much for the share price. The stock closed Friday at EUR 993.00, down 2.1 percent from the previous session, and traded at EUR 994.50 during the day. Since hitting a 52-week high of EUR 2,007.00 in early October, the shares have more than halved. Year-to-date, the decline stands at 36 percent, and the stock sits 50 percent below its 52-week peak.

Momentum gauges offer a glimmer of relief. A Relative Strength Index reading just under 34 puts the shares in oversold territory, hinting at some near-term exhaustion in the downtrend. The stock is trading roughly nine percent below its 50-day moving average and 28 percent under its 200-day line, well beneath its medium-term trend markers.

What the recent run of U.S. defense orders shows is that Rheinmetall's operating business is still moving forward in specific segments, even as the equity labors under valuation concerns and a broader aversion to defense names. The latest bookings give shareholders evidence of continued operational growth — and shift attention toward how smoothly the company executes on its heavily loaded order backlog.

For investors, the Mission Master award remains a footnote to the bigger picture. The more consequential question is whether the shares can stabilize after the steep slide of recent months. Small operational wins like the current U.S. contract are unlikely to move that needle while wider skepticism about defense-sector valuations persists.